Osmotic agents in automated peritoneal dialysis solutions

Contributions to Nephrology

Volumn 129, Issue , 1999, Pages 177-186

  Krediet, Raymond T ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; GLUCAN; GLUCOSE; ICODEXTRIN;

HUMAN; OSMOTIC PRESSURE; PERITONEAL DIALYSIS; REVIEW;

DIALYSIS SOLUTIONS; GLUCANS; GLUCOSE; HUMANS; OSMOTIC PRESSURE; PERITONEAL DIALYSIS;

EID: 0032608666     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060018     Document Type: Article

References (63)

1. Schröppel B, Fischereder M, Wiese P, Segerer S, Huber S, Kretzler M, Heiss P, Sitter T, Schlöndorff D: Expression of glucose transporters in human peritoneal mesothelial cells. Kidney Int 1998;53:1278-1287.
2. Ho-dac-Pannekeet MM, Imholz ALT, Struijk DG, Koomen GCM, Langedijk MJ, Schouten N, De Waart DR, Hiralall JK, Krediet RT: The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995;48:866-875.
3. Heimbürger O, Waniewski J, Werynski A, Lindholm B: A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992;41:1320-1332.
4. Twardowski ZJ, Nolph KD, Khanna R, Prowant B, Ryan LP, Moore HL, Nielsen MP: Peritoneal equilibration test. Perit Dial Bull 1987;7:138-147.
5. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Arisz L: The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis. Clin Nephrol 1987;27:51-55.
6. Krediet RT, Zemel D, Imholz ALT, Struijk DG: Impact of surface area and permeability on solute clearances. Perit Dial Int 1994;14(suppl 3):70-77.
7. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B: Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant 1998;13:1242-1249.
8. Rippe B, Stelin G, Haraldsson B: Computer simulations of peritoneal transport in CAPD. Kidney Int 1991;40:315-325.
9. Ho-dac-Pannekeet MM, Mulder JB, Weening JJ, Struijk DG, Zweers MM, Krediet RT: Demonstration of aquaporin-chip in peritoneal tissue of uremic and CAPD patients. Perit Dial Int 1996;16(suppl 1):54-57.
10. Carlsson O, Nielsen S, Zakaria ER, Rippe B: In vivo inhibition of transcellular water channels (aquaporin-1) during acute peritoneal dialysis in rats. Am J Physiol 1996;271:H2254-H2262.
11. Rippe B, Stelin G: Simulations of peritoneal solute transport during CAPD. Application of twopore formalism. Kidney Int 1989;35:1234-1244.
12. Ho-dac-Pannekeet MM, Schouten N, Langedijk MJ, Hirallal JK, de Waart DR, Struijk DG, Krediet RT: Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996;50:979-986.
13. Raja RM, Cantor RE, Boreyko C, Bushehri H, Kramer MS, Rosenbaum JL: Sodium transport during ultrafiltration peritoneal dialysis. Trans Am Soc Artif Int Organs 1972;18:429-433.
14. Imholz ALT, Koomen GCM, Struijk DG, Arisz L, Krediet RT: Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 1994;46:333-340.
15. Douma CE, de Waart DR, Struijk DG, Krediet RT: Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: A potential role for nitric oxide? Clin Nephrol 1996;45:295-302.
16. Stelin G, Rippe B: A phenomenological interpretation of the variation in dialysate volume with dwell time in CAPD. Kidney Int 1990;38:465-472.
17. Imholz ALT, Koomen GCM, Struijk DG, Arisz L, Krediet RT: The effect of dialysate osmolarity on the transport of low molecular weight solutes and proteins during CAPD. Kidney Int 1993;43:1339-1346.
18. Rubin J, Nolph KD, Popovich RP, Moncrief JW, Prowant B: Drainage volumes during continuous ambulatory peritoneal dialysis. ASAIO J 1997;2:54-60.
19. Canaud B, Liendo-Liendo C, Claret G, Mion H, Mion C: Etude 'in situ' de la cinétique de l'ultrafiltration en cours de dialyse péritonéale avec périodes de diffusion prolongée. Néphrologie 1980;1:126-132.
20. Topley N, Coles GA, Williams JD: Biocompatibility studies on peritoneal cells. Perit Dial Int 1994;14(suppl 3):21-28.
21. Douvdevani A, Rappaport J, Konforty A, et al: Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 1995;6:207-213.
22. Breborowicz A, Rodela H, Oreopoulos DG: Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992;41:1280-1285.
23. Slater ND, Cope GH, Raftery AT: Mesothelial hyperplasia in response to peritoneal dialysis fluid: A morphometric study in the rat. Nephron 1991;58:466-471.
24. DiPaolo N, Garosi G, Petrini G, Monaci G: Morphological and morphometric changes in mesothelial cells during peritoneal dialysis in the rabbit. Nephron 1996;74:594-599.
25. Gotloib L, Shostak A, Wajsbrot V: Detrimental effects of peritoneal dialysis solutions upon in vivo and in situ exposed mesothelium. Perit Dial Int 1997;17(suppl 2):13-16.
26. Yamada K, Miyakasa Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, Miura Y, Suzuki S, Tuchida H, Nimura N, Araki N, Horiachi S: Immunohistochemical study of human advanced glycosylation end products in chronic renal failure. Clin Nephrol 1994;42:354-361.
27. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takozoe K, Katoh N, Hayakawa H, Osaka N, Yamatoto H, Ogawa A, Kubo H, Shigematsa T, Sakai H, Horiachi S: Immunohistochemical detection of advanced glycosylation end products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997;51:182-186.
28. Vlaanderen K, Bos HJ, De Fijter CWH, Oe LP, van der Meulen J, Verbrugh H, Beelen RHJ: Short dwell times reduce the local defence mechanism of chronic peritoneal dialysis patients. Nephron 1991;57:29-35.
29. De Fijter CWH, Verbrugh HA, Oe LP, Peters EDJ, van der Meulen J, Donker AJM, Verhoef J: Peritoneal defence in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992;42:947-950.
30. McGregor SJ, Brock JH, Briggs JD, Junor BJR: Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients. Nephrol Dial Transplant 1987;2:104-108.
31. Miller FN, Nolph KD, Joshua IG, Wiegman DL, Harris PD, Andersen DB: Hyperosmolality, acetate and lactate: Dilatory factors during peritoneal dialysis. Kidney Int 1981;20:397-402.
32. De Fijter CW, Oe PL, Nauta JJ, Van der Meulen J, Verbrugh HA, Verhoef J, Donker AJM: Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994;120:264-271.
33. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC: Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991;40:77-79.
34. Wieslander AP, Deppisch R, Svenson E, Forsbäck G, Speidel R, Rippe B: In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995;15:158-164.
35. Simonsen O, Wieslander A, Landgren C, Rippe B: Less infusion pain and elevated level of cancer antigen 125 by the use of a new and more biocompatible PD fluid. Adv Perit Dial 1996;12:156-160.
36. Rippe B, Christensson A, Haraldsson B, Simonsen O, Stelin G, Weiss L, Nielsen FD, Heimbürger O, Bro S, Friedberg M, Wieslander A: Patient dialysate Ca125 and hyaluronon (HA) after 1, 6 and 12 months of treatment with a PD fluid containing less cytotoxic glucose degradation products. J Am Soc Nephrol 1997;8:182A.
37. Krediet RT, Struijk DG, Koomen GCM, Hoek FJ, Arisz L: The disappearance of macromolecules from the peritoneal cavity during continuous ambulatory peritoneal dialysis is not dependent on molecular size. Perit Dial Int 1990;10:147-152.
38. Mistry CD, Gokal R: Can ultrafiltration occur with a hypo-osmolar solution in peritoneal dialysis? The role for 'colloid' osmosis. Clin Sci 1993;85:495-500.
39. Douma CE, Hirallall JK, De Waart DR, Struijk DG, Krediet RT: Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int 1998;53:1014-1021.
40. Mistry CD, Mallick NP, Gokal R: Ultrafiltration with an isosmotic solution during long peritoneal dialysis exchanges. Lancet 1987;ii:178-182.
41. Mistry CD, Gokal R, Peers E, Midas Study Group: A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994;46:496-503.
42. Krediet RT, Douma CE, Van Olden RW, Ho-dac-Pannekeet MM, Struijk DG: Augmenting solute clearance in peritoneal dialysis. Kidney Int 1998;54:2218-2225.
43. Mistry CD, O'Donoghue DJ, Nelson S, Gokal R, Ballardie FW: Kinetic and clinical studies of β2-microglobulin in continuous ambulatory peritoneal dialysis: Influence of renal and enhanced peritoneal clearances using glucose polymer. Nephrol Dial Transplant 1990;5:13-19.
44. Ho-dac-Pannekeet MM, Atasever B, Struijk DG, Krediet RT: Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 1997;17:144-150.
45. Gokal R, Mistry CD, Peers EM, Midas Study Group: Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. Perit Dial Int 1995;15:226-230.
46. Imholz ALT, Brown CB, Koomen GCM, Arisz L, Krediet RT: The effect of glucose polymers on water removal and protein clearances during CAPD. Adv Perit Dial 1993;9:25-30.
47. Krediet RT, Brown CG, Imholz ALT, Koomen GCM: Protein clearance and icodextrin. Perit Dial Int 1994;14(suppl 2):39-44.
48. Krediet RT, Ho-dac-Pannekeet MM, Imholz ALT, Struijk DG: Icodextrin's effects on peritoneal transport. Perit Dial Int 1997;17:35-41.
49. Wilkie ME, Plant MJ, Edwards L, Brow CB: Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: Extension of CAPD technique survival. Perit Dial Int 1997;17:84-87.
50. Dawnay ABSIJ, Millar DJ: Glycation and advanced glycation end-product formation with icodextrin and dextrose. Perit Dial Int 1997;17:52-58.
51. Liberek T, Topley N, Jörres A, et al: Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration. J Am Soc Nephrol 1993;8:1508-1515.
52. Thomas S, Schenk U, Fisher EP, Mettang T, Passlick-Deetjen J, Kuhlmann U: In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity. Am J Kidney Dis 1997;29:246-253.
53. Jörres A, Gahl GM, Topley N, et al: In vitro biocompatibility of alternative CAPD fluids: Comparison of bicarbonate-buffered and glucose-polymer-based solutions. Nephrol Dial Transplant 1994;9:785-790.
54. Plum J, Lordnejad MR, Grabensee B: Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes. Kidney Int 1998;54:224-235.
55. De Fijter CWH, Verbrugh HA, Oe PL, et al: Biocompatibility of a glucose polymer-containing peritoneal dialysis fluid. Am J Kidney Dis 1993;21:411-418.
56. Davies D: Kinetics of icodextrin. Perit Dial Int 1994;14(suppl 2):45-50.
57. Posthuma N, Ter Wee PM, Verbrugh HA, Oe PL, Peers E, Sayers J, Donker AJM: Icodextrin instead of glucose during daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 1997;123:550-553.
58. Goodship THJ, Lloyd S, McKenzie PW, Earnshaw M, Smeaton I, Bartlett K, Ward MK, Wilkinson R: Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1987;73:471-478.
59. Kopple JJ, Bernard D, Messana J, Swartz R, Bergström J, Lindholm B, Lini V, Brunori G, Leiserowitz M, Bier DM, Stegink DW, Martis L, Boyle LA, Serkes KD, Vonesh E, Jones MJ: Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995;47:1148-1157.
60. Heaton A, Ward MK, Johnston DG, Nicholson DV, Albertsi KGMM, Kerr DNS: Short-term studies on the use of glycerol as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1984;67:121-130.
61. Matthys E, Dolkart R, Lameire N: Extended use of a glycerol-containing dialysate in diabetic CAPD patients. Perit Dial Bull 1987;7:10-15.
62. Daniels FH, Leonard EF, Cortell S: Glucose and glycerol compared as osmotic agents for peritoneal dialysis. Kidney Int 1984;25:10-15.
63. Matthys E, Dolkart R, Lameire N: Potential hazards of glycerol dialysate in diabetic CAPD patients. Perit Dial Bull 1987;7:16-19.